On February 27, Shan Dong Kexing Bioproducts Co.Ltd(688136) released the annual performance express of 2021. During the reporting period, the company’s revenue increased steadily, realizing an operating revenue of 1.285 billion yuan, a year-on-year increase of 5.31%. During the reporting period, the company continued to increase R & D investment, introduce high-end talents, strengthen market development and channel construction, and continuously improve product and market competitiveness.
© China Stock Market News